A study presented today at the European Society of Cardiology meetings in Barcelona (and simultaneously published in the online version of the New England Journal of Medicine) concluded that a new anticoagulant drug - dabigatran - appears at least as effective and as least as safe as Coumadin in preventing stroke in patients with atrial fibrillation.
A true replacement for Coumadin - a drug that is notoriously difficult to use safely, effectively and conveniently - has been a holy grail in medicine for decades. Can we be close at last?
Read about dabigatran, and the likelihood that Coumadin may soon be replaced, here.
Well, that would surely be good news. I hope it works
can ximalgatran replace warfarin for metaalic valve replcement for prevention of thrombi?